Skip to content
Dfnet logo
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
    • User Community
  • About
    • Careers
  • Contact Us
  • My Account
  • My Account
    • Log out
Menu
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
    • User Community
  • About
    • Careers
  • Contact Us
  • My Account
  • My Account
    • Log out
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
    • Source Verification
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
    • User Community
  • About Us
    • Careers
Menu
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
    • Source Verification
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
    • User Community
  • About Us
    • Careers
  • Contact Us
  • My Account
  • Contact Us
Menu
  • Contact Us
Schedule a Demo

iPrEx OLE Study: Gladstone Institute

  • Home
  • Blog
  • iPrEx OLE Study: Gladstone Institute

After the success of iPrEx, DF/Net continued working with the Gladstone Institute, providing the data management for iPrEx OLE. iPrEx OLE (Open Label Extension) is a continuation of the iPrEx study designed to provide additional information about the safety of PrEP and the behavior of people taking PrEP over a longer term. It is hoped that participants’ knowledge that Truvada PrEP provides some protection against HIV infection, and the fact that all HIV-negative participants in iPrEx OLE know that they are receiving Truvada PrEP and not a placebo, will lead to increased use of the study drug by participants in iPrEx OLE, and increased protection against HIV infection.

iPrEx OLE started enrollment on June 13th, 2011 at the San Francisco Department of Public Health and closed enrollment in July of 2012 at Investigaciones Medicas en Salud in Lima, Peru. A total of 1,770 participants enrolled in iPrEx OLE at 11 sites in six countries. Results from this open label extension phase of the study are expected by the first quarter of 2014.

The 11 participating sites for this study are located in Peru, Ecuador, Brazil, the United States, South Africa and Thailand.

For more information on iPrEx OLE, please refer to their web site at:

http://www.iprexole.com/index.html

Share:

We’d Love to Tailor The Perfect Software + Services Solution For You

Orange dots
Book A Call Now
Dfnet logo
Linkedin Youtube

DFnet is a healthcare technology company that provides eClinical solutions, including electronic data capture, eSource, and data management services. We bring more flexibility, better data quality, and greater efficiency to clinical trials everywhere in the world.

2023 © DF/Net Research, Inc. All Rights Reserved

Company

  • About Us
  • Blog
  • Meet the team
  • Privacy Policy
  • Cookie Policy

Our Work

  • Solutions
  • Services
  • Industries
  • Resources

Stay in Touch

  • Contact Us
  • Schedule a Demo
  • Join the Community

We use cookies

This website automatically uses the cookies needed to optimize your navigation. To allow additional cookies used to personalize content relevant to you, click “YES, I ACCEPT.”

Yes, I accept
Learn More